Published on:

Fen-phen litigation award is upheld

A federal appeals court this week rejected challenges to the attorney fee award in the fen-phen diet drug litigation. The amount of the product liability award, though large, was deemed not excessive in this extraordinary case.

To read more about the Fen-phen litigation award.